Physician Assisted Suicide for Depression in the Netherlands: How It Works, Who Qualifies, and the Safeguards in Practice

Introduction and Core Principles

In the Netherlands, physician assisted suicide for depression is legally available under strict conditions. This overview explains how the legal framework operates in practice, who may qualify, and the safeguards intended to protect patients. The information below reflects current practice as of 2025 and is intended for general informational and educational purposes. It does not constitute medical or legal advice. If you or someone you know is in immediate danger, contact local emergency services without delay.

Legal Context and Key Definitions

Physician assisted suicide and voluntary active euthanasia are both governed under the same legal framework in the Netherlands. The central law is the Termination of Life on Request and Assisted Suicide (Review Procedures) Act, often shortened to the WTL. This Act sets out the conditions under which a physician can legally perform assisted suicide or euthanasia. Courts have consistently held that the law can extend to patients with severe and treatment-resistant mental suffering, including major depressive disorder, when specific criteria are met. Related practices, such as physician assisted suicide, involve a physician providing the means and oversight, while voluntary active euthanasia refers to the physician directly administering the substance.

Eligibility Criteria for Depression

Eligibility for physician assisted suicide in cases of severe depression is narrow and requires careful assessment. A patient must experience enduring and unbearable psychological suffering with no prospect of meaningful improvement. The suffering must be considered hopeless and intolerable to the patient. In addition, the request must be voluntary and well-considered, with the patient demonstrating persistent desire over a sufficient period. The patient must also have decision-making capacity and be experiencing severe and treatment-resistant major depressive disorder. Treatment resistance implies that the patient has not responded adequately to a full course of evidence-based treatments, including psychotherapy, pharmacotherapy, and where applicable, electroconvulsive therapy (ECT).

Clinical Assessment Requirements

Two independent physicians must evaluate the patient. One of them must be a psychiatrist or another specialist with expertise in mental health. These assessments aim to confirm the diagnosis, verify treatment resistance, ensure the absence of treatable conditions that could be contributing to suffering, and evaluate the patient’s capacity to make a reasoned request. The process may involve multidisciplinary review, documentation of prior treatment attempts, and clarification of whether all reasonable alternatives have been explored.

The Review and Approval Process

Once eligibility is preliminarily determined, the request undergoes a formal review. The attending physician must discuss the request in multiple consultations, allowing time for reflection and confirmation of the patient’s choice. The case is then submitted to a regional review committee composed of medical and legal experts. This committee examines whether all statutory criteria have been met and whether the procedure is permissible. If the committee approves, the physician may proceed with physician assisted suicide under strict reporting obligations. Accurate, detailed documentation is required at each stage to ensure transparency and compliance with ongoing oversight.

Oversight, Monitoring, and Reporting

Oversight of physician assisted suicide for depression in the Netherlands is conducted through mandatory reporting to regional review committees and a national monitoring body. These bodies review anonymized reports to assess adherence to legal criteria and to identify patterns or systemic concerns. The reporting framework tracks variables such as diagnosis, treatment history, capacity assessment, and the nature of the suffering described. While individual cases remain confidential, aggregate data are published periodically to inform public and professional understanding. This oversight aims to balance respect for patient autonomy with the protection of vulnerable populations.

Practical Considerations and Limitations

Access to physician assisted suicide for depression can vary across regions due to differences in available expertise, local protocols, and committee workload. Patients and clinicians should be prepared for a potentially lengthy evaluation and review process. Not all psychiatrists or institutions participate, and referrals may be necessary. Ethical consultations and second opinions are commonly used to clarify clinical and procedural aspects. Families and support networks may play important roles in understanding the patient’s suffering and decision-making context, while respecting the patient’s autonomy.

Comparison With Other Mental Health Conditions

While depression is one of the mental health conditions considered under the WTL, the pathway and frequency of approval can differ from conditions such as dementia or neurodegenerative disorders. Depression-related requests often involve more intensive assessments of treatment history and capacity, given the fluctuating nature of the illness and the availability of a wide range of treatments. The table below summarizes key aspects relevant to depression compared with other commonly discussed conditions under the Act.